{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:39:07Z","timestamp":1648748347709},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s10354-014-0294-9","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T07:23:55Z","timestamp":1406705035000},"page":"363-371","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bull\u00f6ses Pemphigoid \u2013 Diagnostik und Therapie"],"prefix":"10.1007","volume":"164","author":[{"given":"Andrea","family":"Kneisel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"issue":"1","key":"294_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","volume":"32","author":"WF Lever","year":"1953","unstructured":"Lever WF. Pemphigus. Medicine (Baltimore). 1953;32(1):1\u2013123.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"294_CR2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","volume":"161","author":"G Marazza","year":"2009","unstructured":"Marazza G, Pham H, Sch\u00e4rer L, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;161(4):861\u20138.","journal-title":"Br J Dermatol"},{"issue":"5","key":"294_CR3","first-page":"434","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Br\u00f6cker E, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges. 2009;7(5):434\u201340.","journal-title":"J Dtsch Dermatol Ges"},{"key":"294_CR4","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris\u2013incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.","journal-title":"BMJ"},{"issue":"2 Pt 1","key":"294_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","volume":"41","author":"M Jung","year":"1999","unstructured":"Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol. 1999;41(2 Pt 1):266\u2013268.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"294_CR6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","volume":"165","author":"B Cort\u00e9s","year":"2011","unstructured":"Cort\u00e9s B, Marazza G, Naldi L, Combescure C, Borradori L, Group ABDSS. Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol. 2011;165(2):368\u201374.","journal-title":"Br J Dermatol"},{"issue":"6","key":"294_CR7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","volume":"141","author":"P Joly","year":"2005","unstructured":"Joly P, Benichou J, Lok C, et al. Prediction of survival for patients with bullous pemphigoid: a prospective study. Arch Dermatol. 2005;141(6):691\u20138.","journal-title":"Arch Dermatol"},{"issue":"7","key":"294_CR8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","volume":"138","author":"B Rzany","year":"2002","unstructured":"Rzany B, Partscht K, Jung M, et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol. 2002;138(7):903\u20138.","journal-title":"Arch Dermatol"},{"issue":"3","key":"294_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","volume":"132","author":"S Bastuji-Garin","year":"1996","unstructured":"Bastuji-Garin S, Joly P, Picard-Dahan C, et al. Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol. 1996;132(3):272\u20136.","journal-title":"Arch Dermatol"},{"issue":"4","key":"294_CR10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clindermatol.2013.01.007","volume":"31","author":"E Ruocco","year":"2013","unstructured":"Ruocco E, Wolf R, Caccavale S, Brancaccio G, Ruocco V, Lo Schiavo A. Bullous pemphigoid: associations and management guidelines: facts and controversies. Clin Dermatol. 2013;31(4):400\u201312.","journal-title":"Clin Dermatol"},{"issue":"3","key":"294_CR11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","volume":"131","author":"S Bastuji-Garin","year":"2011","unstructured":"Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol. 2011;131(3):637\u201343.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"294_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","volume":"30","author":"G Di Zenzo","year":"2012","unstructured":"Di Zenzo G, Della Torre R, Zambruno G, Borradori L. Bullous pemphigoid: from the clinic to the bench. Clin Dermatol. 2012;30(1):3\u201316.","journal-title":"Clin Dermatol"},{"issue":"4","key":"294_CR13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.1990.tb01447.x","volume":"123","author":"VA Venning","year":"1990","unstructured":"Venning VA, Wojnarowska F. The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol. 1990;123(4):439\u201345.","journal-title":"Br J Dermatol"},{"issue":"1","key":"294_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00403-013-1399-5","volume":"306","author":"E Ong","year":"2014","unstructured":"Ong E, Goldacre R, Hoang U, Sinclair R, Goldacre M. Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999\u20132011. Arch Dermatol Res. 2014;306(1):75\u201380.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"294_CR15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","volume":"66","author":"D Murrell","year":"2011","unstructured":"Murrell D, Daniel B, Joly P, et al. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol. 2011;66(3):479\u201385.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"294_CR16","first-page":"4","volume":"17","author":"M Pf\u00fctze","year":"2007","unstructured":"Pf\u00fctze M, Niedermeier A, Hertl M, Eming R. Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus. Eur J Dermatol. 2007;17(1):4\u201311.","journal-title":"Eur J Dermatol"},{"issue":"10","key":"294_CR17","first-page":"844","volume":"9","author":"A Kneisel","year":"2011","unstructured":"Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 1: clinical manifestations. J Dtsch Dermatol Ges. 2011;9(10):844\u201356. quiz 857.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"11","key":"294_CR18","first-page":"927","volume":"9","author":"A Kneisel","year":"2011","unstructured":"Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy. J Dtsch Dermatol Ges. 2011;9(11):927\u201347.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"294_CR19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","volume":"69","author":"M S\u00e1rdy","year":"2013","unstructured":"S\u00e1rdy M, Kostaki D, Varga R, Peris K, Ruzicka T. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid. J Am Acad Dermatol. 2013;69(5):748\u201353.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"294_CR20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","volume":"131","author":"G Di Zenzo","year":"2011","unstructured":"Di Zenzo G, Thoma-Uszynski S, Calabresi V, et al. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol. 2011;131(11):2271\u201380.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"294_CR21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clim.2012.02.003","volume":"143","author":"L Fania","year":"2012","unstructured":"Fania L, Caldarola G, M\u00fcller R, et al. IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses. Clin Immunol. 2012;143(3):236\u201345.","journal-title":"Clin Immunol"},{"issue":"5","key":"294_CR22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","volume":"119","author":"S Hofmann","year":"2002","unstructured":"Hofmann S, Thoma-Uszynski S, Hunziker T, et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol. 2002;119(5):1065\u201373.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"294_CR23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2133.2009.09266.x","volume":"161","author":"C Feliciani","year":"2009","unstructured":"Feliciani C, Caldarola G, Kneisel A, et al. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Br J Dermatol. 2009;161(2):306\u201312.","journal-title":"Br J Dermatol"},{"key":"294_CR24","doi-asserted-by":"crossref","unstructured":"Schmidt T, Sitaru C, Amber K, Hertl M. BP180 and BP230 specific IgG autoantibodies in pruritic disorders of the elderly \u2013 a pre-clinical stage of bullous pemphigoid? Br J Dermatol. 2014. doi:10.1111\/bjd.12936.","DOI":"10.1111\/bjd.12936"},{"issue":"7","key":"294_CR25","first-page":"492","volume":"10","author":"N, Knuth-Rehr Beek van","year":"2012","unstructured":"van Beek N, Knuth-Rehr, Altmeyer P, et al. Diagnostics of autoimmune bullous diseases in German dermatology departments. J Dtsch Dermatol Ges. 2012;10(7):492\u20139.","journal-title":"J Dtsch Dermatol Ges"},{"key":"294_CR26","unstructured":"Feliciani C, Borradori L, Jonkman MF, et al. Development of European Guidelines Autoimmune bullous diseases (guided by the EDF and EADV): pemphigoid. S2 guidelines for diagnosis and treatment statements. 2014. (in press)."},{"issue":"5","key":"294_CR27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau J, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"294_CR28","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","volume":"129","author":"P Joly","year":"2009","unstructured":"Joly P, Roujeau J, Benichou J, et al. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol. 2009;129(7):1681\u20137.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"294_CR29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/jdv.12153","volume":"28","author":"JB Terra","year":"2014","unstructured":"Terra JB, Potze WJ, Jonkman MF. Whole body application of a potent topical corticosteroid for bullous pemphigoid. J Eur Acad Dermatol Venereol. 2014;28(6):712\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"294_CR30","first-page":"CD002292","volume":"6","author":"G Kirtschig","year":"2010","unstructured":"Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;6(10):CD002292.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"294_CR31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archdermatol.2011.54","volume":"147","author":"C Le Roux-Villet","year":"2011","unstructured":"Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, et al. Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol. 2011;147(7):843\u20139.","journal-title":"Arch Dermatol"},{"issue":"3","key":"294_CR32","first-page":"370","volume":"138","author":"LS Chan","year":"2002","unstructured":"Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370\u20139.","journal-title":"Arch Dermatol"},{"issue":"2","key":"294_CR33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejogrb.2009.05.012","volume":"145","author":"K Semkova","year":"2009","unstructured":"Semkova K, Black M. Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol. 2009;145(2):138\u201344.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-014-0294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-014-0294-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-014-0294-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:11:09Z","timestamp":1559146269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-014-0294-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":33,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["294"],"URL":"https:\/\/doi.org\/10.1007\/s10354-014-0294-9","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}